AbbVie Inc. Logo

AbbVie Inc. (ABBV)

BMV

Currency in MXN
4,495.00
0.00 (0.00%)

Closed

Aug 21, 2026

Day's Range

4,495.00
4,495.00

52 wk Range

3,420.00
4,635.00

Overview - ABBV - AbbVie Inc.

Key Statistics

Valuation

Enterprise Value

135.29T

P/E (Trailing)

‪75.19‬

PEG Ratio

‪0.26‬

Price / Sales (TTM)

‪123.36‬

Price / Book

‪-1,350.48‬

EV / EBITDA

‪260.29‬

Profitability

Gross Margin

‪74.74%‬

Profit Margin

‪9.80%‬

Operating Margin

‪40.03%‬

Return on Assets

‪10.51%‬

Return on Equity

‪-129.67%‬

Ownership

Shares Outstanding

1.76B

Float

1.76B

Held by Insiders

‪0.11%‬

Held by Institutions

‪77.43%‬

Price stats

Beta

‪0.28‬

50-Day Avg

‪4,304.36‬

200-Day Avg

‪3,988.14‬

Dividends

Payout Ratio

‪190.39%‬

Frequency

Quarterly

Shariah Compliance

Shariah Compliant

Report Date: Feb 18, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - ABBV - AbbVie Inc.

Peers - ABBV - AbbVie Inc.

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on BMV.

Profile Summary - ABBV - AbbVie Inc.

About

AbbVie Inc. is a research-based biopharmaceutical company that discovers, develops, manufactures, and commercializes innovative medicines and therapies worldwide. The company maintains a strong focus on immunology, offering treatments like Humira, Skyrizi, and Rinvoq for autoimmune and inflammatory conditions in…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees57K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.